These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10662390)

  • 21. Pharmacoeconomics and immunotherapy.
    Berto P
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():12-6. PubMed ID: 18924461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of pharmacoeconomics analyses to health protection].
    Drozd M
    Wiad Lek; 2002; 55 Suppl 1():76-9. PubMed ID: 15002222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of pharmacoeconomics: a commentary.
    Langley PC
    Clin Ther; 1997; 19(4):762-9; discussion 760-1. PubMed ID: 9377619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacoeconomic impact of compliance].
    Agh T; Mészáros A
    Acta Pharm Hung; 2010; 80(2):75-80. PubMed ID: 20684381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role for pharmacoeconomics in developing countries?
    Harper JR
    Pharmacoeconomics; 2011 May; 29(5):435-6; author reply 436-7. PubMed ID: 21504243
    [No Abstract]   [Full Text] [Related]  

  • 26. The emerging government requirement for economic evaluation of pharmaceuticals.
    Drummond M
    Pharmacoeconomics; 1994; 6 Suppl 1():42-50. PubMed ID: 10155586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is next for pharmacoeconomics and outcomes research in Asia?
    Doherty J; Kamae I; Lee KK; Li H; Li SC; Liu GG; Tarn YH; Yang BM
    Value Health; 2004; 7(2):118-32. PubMed ID: 15164802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pharmacoeconomics on company research and development decisions.
    Grabowski H
    Pharmacoeconomics; 1997 May; 11(5):389-97. PubMed ID: 10168028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging role of pharmacoeconomics in the research and development decision-making process.
    DiMasi JA; Caglarcan E; Wood-Armany M
    Pharmacoeconomics; 2001; 19(7):753-66. PubMed ID: 11548911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacoeconomics--an aid to better decision-making.
    Arenas-Guzman R; Tosti A; Hay R; Haneke E;
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():34-9. PubMed ID: 16120204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of pharmacoeconomics in current Indian healthcare system.
    Ahmad A; Patel I; Parimilakrishnan S; Mohanta GP; Chung H; Chang J
    J Res Pharm Pract; 2013 Jan; 2(1):3-9. PubMed ID: 24991597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value-Based Pricing in Latin America: How Far Away Are We?
    Mejía A; Gilardino R; Kristensen FB; Garrison LP;
    Value Health Reg Issues; 2018 Dec; 17():219-223. PubMed ID: 30528780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical economics and health policy research using administrative data.
    Lyles A
    Clin Ther; 2004 Jul; 26(7):1122-3. PubMed ID: 15336477
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness analysis: from science to application.
    Berger ML; Teutsch S
    Med Care; 2005 Jul; 43(7 Suppl):49-53. PubMed ID: 16056009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacoeconomics and macular degeneration.
    Brown GC; Brown MM; Brown H; Godshalk AN
    Curr Opin Ophthalmol; 2007 May; 18(3):206-11. PubMed ID: 17435427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value-Based Medicine and Pharmacoeconomics.
    Brown GC; Brown MM
    Dev Ophthalmol; 2016; 55():381-90. PubMed ID: 26501688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk sharing methods in middle income countries].
    Inotai A; Kaló Z
    Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacoeconomics.
    Sule NS; Nerurkar RP; Kamath SA
    J Assoc Physicians India; 2002 Aug; 50():1057-62. PubMed ID: 12421032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacoeconomic picture in Saudi Arabia.
    Alkhenizan A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):483-90. PubMed ID: 24953076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.